PG-530742

· Procter & Gamble

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG-530742, covering 2011-11-08 to 2011-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis [Phase 2]